Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Newly discovered recessive neurodevelopmental disorder may be most prevalent ever

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that appears to be the most prevalent ever discovered. The condition is caused by changes in a small noncoding gene called RNU2-2. It is estimated to affect thousands of individuals in the United States and account for about 10% of all recessive NDD cases with a known genetic cause.

The work was done in collaboration with U.S. collaborators in the Undiagnosed Diseases Network led by colleagues at Stanford University and international collaborators in the United Kingdom, the Netherlands, Belgium, and Italy. The findings, published in the March 30 issue of Nature Genetics, provide long-awaited answers for many families and may inform future drug development.

The team found that the disorder is caused by a near-complete absence of a molecule called U2-2 RNA, which is produced by the RNU2-2 gene. Children with the condition typically inherit one altered copy of the gene from each parent, although sometimes changes arise spontaneously by genetic mutation. While the parents are unaffected, the combined effect on both copies of the gene in their children leads to disrupted brain development in their child.

Eyal Aharoni — Breaking the Moral Turing Test

Dr. discusses one of the most provocative frontiers in technology: the automation of moral judgement — in his talk focusses on outcomes of a comparative moral Turing test (AI outperforms humans across a range of metrics), as well as AI assisted medical triage!

Link in reply🔗

Eyal Aharoni


Dr. Eyal Aharoni (Georgia State University) to the Future Day 2026 stage to discuss one of the most provocative frontiers in technology: the automation of moral judgement.

Breaking the Moral Turing Test: Studies of human attribution and deference to AI moral judgment and decision-making.

Aubrey de Grey — How close are we to robust mouse rejuvenation, and why does that matter?

Full talk at Future Day 2026 — link in reply 🔗


Polymath and trailblazer in bio-rejuvenation Aubrey de Grey gave a talk at Future Day 2026 on the next phase of robust mouse rejuvenation trials!

Synopsis: The “damage repair” approach to bringing aging under medical control has made huge strides since I first proposed it 25 years ago. However, since it is a divide-and-conquer strategy, we should not be surprised at the absence of progress in the “bottom line” of life extension, even in mice. Can we realistically expect that to change any time soon? I will present reasons to believe that we can, in the form of accelerating progress in proofs of efficacy of individual treatments, together with initial proof of concept that combining damage repair modalities will give additive benefits.

0:00 Intro.
0:29 Talk starts.
1:28 Age related vs infectious diseases.
3:26Epidemic of the chronic conditions of late life — why?
4:42 Ways to be sick: popular view.
7:10 Aging in three words (metabolism, damage, pathology)
11:46 Ways to be sick: correct view.
15:29 What we do these days against aging — Geriatrics.
18:21 Gerontology: A more promising approach?
20:57 Metabolism is complex.
22:37 Maintenance: A common sense alternative.
24:39 Comparison: car maintenance.
26:00 7 deadly things.
29:17 Cell 153:1194 — too many citations to count.
30:22 The first round of the race to RMR (Robust Mouse Rejuvenation)
38:43 Females: yay, additivity!
40:09 Males: messier, but mostly the same story.
41:02 What health indices did we measure?
43:23 RMR2: ASAP! See levf.org/rmr2
46:30 AUBRAI
48:36 Learn more and help!
51:11 How has the longevity industry vibe changed over the last 7 years?
56:32 LEV Foundation only org working on this combination of damage repair regimes.
57:55 Has AI made progress in helping solve aging? In-silico medicine.
1:01:16 Changes to seven deadly things?
1:04:54 Hallmarks of aging — defacto taxonomy — difficulty translating to other taxonomies?
1:06:17 Has the damage repair methodology been attracting people over?
1:09:56 Stradelling both academia and private industry — but what about the state?
1:13:36 Robust Mouse Rejuvenation timelines under ideal funding.
1:19:49 Infections.
1:25:46 Treatment cadence.

#rejuvenation #medicine #health #aging #ageing.

This tiny implant, smaller than a grain of salt, can read your brain

A new neural implant is so small it can rest on a grain of salt, yet it can track and wirelessly transmit brain activity for over a year. It’s powered by laser light that safely passes through tissue and communicates using tiny infrared signals. This ultra-miniature device could transform how scientists study the brain without invasive wiring.

A World Where Anyone Who Needs a Bone Marrow Transplant Gets One — Kevin Caldwell — Ossium Health

Imagine a world where anyone who needs a bone marrow transplant can get one — on demand. No more desperate donor searches or deadly delays. Kevin Caldwell, Co-Founder & CEO, Ossium Health.


Bone marrow transplants have always depended on finding the right donor at the right time. But what if bone marrow could be stored, shipped, and used on demand—just like a drug? That’s exactly what Ossium Health is now showing in human clinical data.

Kevin Caldwell is the Co-Founder, CEO, and President of Ossium Health (https://ossiumhealth.com/), a clinical-stage bioengineering company pioneering off-the-shelf, cryopreserved bone marrow therapies derived from deceased organ donors.

Under Kevin’s leadership, Ossium has developed a novel platform designed to solve one of the most persistent challenges in transplantation medicine: timely access to compatible bone marrow for patients with life-threatening hematologic malignancies such as Acute Myeloid Leukemia. The company’s approach enables on-demand delivery of viable marrow cells, bypassing the logistical and biological constraints of traditional donor matching and scheduling.

Since its founding, Kevin has scaled Ossium from an early-stage startup into a clinical-stage company with a robust network of over 50 strategic partnerships across supply, clinical development, and commercial channels. He has led multiple financings and secured a landmark contract with the Biomedical Advanced Research and Development Authority, validating Ossium’s relevance to national health preparedness and biomanufacturing resilience.

Forgotten FPS sequel Heretic 2 gets a ‘reverse-engineered sourceport’ that fixes bugs, improves the framerate and adds ‘lots of cosmetic improvements’

Dubbed Heretic2R, the sourceport introduces a bunch of new technical features to the elf wizard Corvus’ second adventure. For starters, it adds widescreen support with automatic HUD scaling, and unlocks the framerate to a theoretical maximum of 1,000 FPS.

On top of this, Heretic 2R ensures that in-game special effects update at the appropriate rendering framerate, improves map loading times, and makes “lots of cosmetic improvements” so that “the game plays as you remember it, not as it actually played”. Which sounds very remaster-y to me.

/* */